HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The relationship between lipid risk score and new-onset hypertension in a prospective cohort study.

AbstractBackground:
Dyslipidemia and hypertension are both important risk factors for atherosclerotic cardiovascular diseases. However, the relationship between dyslipidemia and incident hypertension remains to be elucidated comprehensively. The main purpose of this study was to construct the lipid risk score to explore the risk prediction effect of integrated lipid indices on new-onset hypertension.
Methods:
This prospective cohort study with 2116 non-hypertensive subjects was conducted from 2009 to 2020. New hypertension events during the follow-up period were recorded and verified. The lipid risk score was calculated by summing coded total cholesterol, triglyceride, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol weighted with corresponding effect sizes. Cox regression analysis was used to estimate the association between the lipid risk score or lipid indices and incident hypertension in the subgroup of age (< 55 and≥ 55 years at baseline).
Results:
After a median of 10.75-year follow-up, 637 incident hypertension cases were identified. The restricted cubic spline showed that the lipid risk score had a positive linear correlation with hypertension (P< 0.001). Among people< 55 years, with every increase of 0.94 in lipid risk score, the risk of hypertension increased by 37% (adjusted HR [95%CI]: 1.369 [1.164-1.610]). This association was not modified by overweight or obesity.
Conclusions:
The integrated lipid risk score, independent of traditional risk factors, has a significantly predictive effect on hypertension in people younger than 55 years. This finding may aid in identifying high-risk individuals for hypertension, as well as facilitating early intervention and management to reduce adverse cardiovascular events. Comprehensive lipid management should be attached importance in the prevention and control of hypertension.
AuthorsHankun Xie, Qian Zhuang, Jialing Mu, Junxiang Sun, Pengfei Wei, Xianghai Zhao, Yanchun Chen, Jiayi Dong, Changying Chen, Lai Wei, Yunjie Yin, Song Yang, Chong Shen
JournalFrontiers in endocrinology (Front Endocrinol (Lausanne)) Vol. 13 Pg. 916951 ( 2022) ISSN: 1664-2392 [Print] Switzerland
PMID36246874 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 Xie, Zhuang, Mu, Sun, Wei, Zhao, Chen, Dong, Chen, Wei, Yin, Yang and Shen.
Chemical References
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Triglycerides
Topics
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Dyslipidemias (epidemiology)
  • Humans
  • Hypertension (epidemiology, etiology)
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • Triglycerides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: